EAU2007: uroweb.org - Official Webcasts

Plenary Sessions

Plenary Session 3

Chairs: F.C. Hamdy, Sheffield (GB), U. Jonas, Hanover (DE)

	Debate Management of treatment failure after radical prostatectomy M. Marberger, A. Heidenreich, M. Mason, B. Tombal

	Societé Internationale d’Urologie (SIU) lecture Prostate cancer in the developing countries: Characteristics and management Dr. R. Umbas

	Ureteral Stone Guidelines, a collaborative effort: AUA Dr. D.G. Assimos

	Ureteral Stone Guidelines, a collaborative effort: EAU Dr. H.G. Tiselius

	State-of-the-art lecture Testosterone and sexual function: Myths and facts Dr. F. Montorsi

	Pan African Urological Surgeons Association (PAUSA) lecture Is prostate cancer more common and more aggresive in African men? Dr. C.F. Heyns

	Debate: Open versus laparoscopic versus robotic surgery in pelvic oncology – what are the benefits? Dr. C.C. Schulman

	Debate Open versus laparoscopic versus robotic surgery in pelvic oncology – what are the benefits? Dr. U.E. Studer

	Debate Open versus laparoscopic versus robotic surgery in pelvic oncology – what are the benefits? Dr. J.U. Stolzenburg

	Debate Open versus laparoscopic versus robotic surgery in pelvic oncology – what are the benefits? Dr. T.E. Ahlering

	Rebuttal Dr. U.E. Studer

	Rebuttal Dr. J.U. Stolzenburg

	Rebuttal Dr. T.E. Ahlering

	Panel Discussion C.C. Schulman, U.E. Struder, J.U. Stolzenburg, T.E. Ahlering

	An update on ERSPC - Do we have to identify and treat all screen detectable prostate cancers in the low PSA ranges Dr. F.H. Schröder

	Experiences including 5 year results of 180 cases treated with botulinum-A toxin injections into the detrusor muscle for overactive bladder refractory to anticholinergics Dr. D. Schmid

	Oncology Dr. A.R. Zlotta

	Prostate disease Dr. G.N. Thalmann

	Minimally invasive therapies Dr. G. Janetschek

	Paediatrics Dr. G.A. Bogaert

	Stone disease Dr. P. Dobronski

	Reconstruction/Andrology Dr. A. Stenzl

<< Return to previous page